tiprankstipranks
Silexion Therapeutics (SLXN)
NASDAQ:SLXN
US Market
SLXN
Silexion Therapeutics
RESEARCH TOOLSreports

Silexion Therapeutics (SLXN) Stock News & Sentiment

214 Followers
Silexion Therapeutics Announces Immediate Board Membership Change
Premium
Company Announcements
Silexion Therapeutics Announces Immediate Board Membership Change
19d ago
8K
SLXN
Silexion gains approval for SIL204 pancreatic cancer trial
Premium
Company Announcements
Silexion gains approval for SIL204 pancreatic cancer trial
20d ago
8K
SLXN
Silexion Shareholders Reject Capital Increase and Plan Amendments
Premium
Company Announcements
Silexion Shareholders Reject Capital Increase and Plan Amendments
21d ago
8K
SLXN
Silexion Therapeutics is developing a potential “holy grail” play in precision oncology (NASDAQ: SLXN)
Premium
TipRanks Newswire
Silexion Therapeutics is developing a potential “holy grail” play in precision oncology (NASDAQ: SLXN)
2M ago
SLXN
Silexion Highlights SIL204 RNAi Pancreatic Cancer Program Progress
Premium
Company Announcements
Silexion Highlights SIL204 RNAi Pancreatic Cancer Program Progress
2M ago
8K
SLXN
Silexion outlines 2026 plans after transformational 2025 progress
Premium
Company Announcements
Silexion outlines 2026 plans after transformational 2025 progress
3M ago
8K
SLXN
Silexion Therapeutics Submits Phase 2/3 Trial Application
Premium
Company Announcements
Silexion Therapeutics Submits Phase 2/3 Trial Application
4M ago
8K
SLXN
More SLXN News >

SLXN News on the Web

Top Silexion Executive Quietly Unloads a Chunk of Company Stock
TipRanks News
Bearish
Silexion Therapeutics Announces Immediate Board Membership Change
TipRanks News
Bearish
Analysts Are Bullish on These Healthcare Stocks: Maze Therapeutics, Inc. (MAZE), Merck & Company (MRK)
TipRanks News
Neutral
Silexion Granted Approval to Launch Human Trials That Could Redefine the Future of Cancer Treatment
GuruFocus News
Bullish
Silexion Therapeutics approved to initiate Phase 2/3 clinical trial of SIL204
TipRanks News
Bullish
Silexion gains approval for SIL204 pancreatic cancer trial
TipRanks News
Neutral
Silexion Shareholders Reject Capital Increase and Plan Amendments
TipRanks News
Bearish
Analysts Offer Insights on Healthcare Companies: Gossamer Bio (GOSS) and Silexion Therapeutics (SLXN)
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SLXN’s Media Buzz Sentiment?
Currently, no data Available
What is SLXN’s weekly average amount of articles?
Currently, no data Available
What is SLXN’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
AORTArtivion
TXTMProText Mobility
STAAStaar Surgical
IVVDInvivyd
ALLOAllogene Therapeutics
Showing the stocks with the most bullish news sentiment over the past week